FP2030
menu
banner
Pfizer

Non-Government Partner

Pfizer

Pfizer, in collaboration with various organizations, has made significant commitments to support the Global Strategy on Women's, Children's, and Adolescent Health.

One of their key initiatives is the partnership with the Family Planning 2020 (FP2020) global partnership, which aims to expand access to voluntary family planning for 120 million additional women by the end of 2020.

Commitments made to:

FP2020
At A Glance
visionVision

Pfizer Inc. and a consortium of donors are launching a public-private collaboration to broaden access to Sayana Press, Pfizer’s injectable contraceptive. The donor consortium is supporting the collaboration with over US$270 million in investments between 2017, when the commitment was made, and 2022.

objectives

Pfizer Commitment Narratives

  • Expand access to voluntary family planning for 120 million additional women by the end of 2020.
  • Provide affordable contraceptives, such as Sayana® Press, to qualified purchasers in FP2020 countries.
  • Improve maternal and child health outcomes by reducing maternal, newborn, and under-five mortality rates.
  • Promote universal access to sexual and reproductive health and rights (SRHR) through informed decision-making, awareness, and education.
  • Contribute to achieving universal health coverage, including essential health services, medicines, and vaccines.
  • Work towards eradicating extreme poverty and ensuring equitable access to quality education.
  • Eliminate harmful practices, discrimination, and violence against women and girls.
  • Foster global partnerships for sustainable development by collaborating at global, regional, and country levels.
View Full Commitmentarrows
become a fp2030 partner

Become an FP2030 Partner

close
Back to Top